Daryl L. Thompson
Daryl L. Thompson is an American inventor and entrepreneur whose work focuses on pharmaceutical and biological research.
Life and career
Since 2010, Daryl L. Thompson has served as President and Director of Scientific Initiatives at Global Research and Discovery Group (GRDG Sciences, LLC) in Winter Haven, FL, which is a private research and development organization. Some of the current projects are:
- Linebacker - multi-faceted therapeutic platform for metabolic, neurologic, cancer, and infectious diseases[1]
- 3F Mosquito Avoidance Technology[1]
- Sweet Sense Sugar - a low Glycemic Index sugar[2]
- Pandemic Response Strategies and Technology - including Equivir, a patent pending therapeutic successfully tested against Rhinovirus, Influenza, Cholera and in a Biosafety Level 4 facility, Ebola.
Thompson is Director of Scientific Initiatives and a member of the Board of Directors of Global BioLife, Inc.[3], a partnership formed to develop and commercialize some of the GRDGS technology, which includes former Assistant Surgeon General of the United States Dr. Roscoe M. Moore, Jr. as Senior Scientific Adviser[4]
Thompson was previously President of ATM Metabolics, LLC which specializes in the development of food supplements and pharmaceuticals naturally derived from phyto-chemical platforms aimed at preventing and reversing metabolic and neurological diseases.
Thompson was a founder, partner, and served as senior vice president and director of research at Solution Health Systems, Boca Raton, FL, from 2003 to 2006. During that time, he launched one of GNC’s (General Nutrition Centers, Inc.) highest-selling food supplements, the Grapefruit Solution.
In 2000, Thompson was recognized for designing a non-invasive glucose meter and received the Diabetes World Humanitarian Award from the Diabetes Research Center.
Inventions and Patents
Thompson has successfully developed, patented, and/or marketed:
- Composition and method for the treatment of neurological disorders, Patent #8,034,838[5]
- Composition and method for treating diabetes and metabolic disorders, Patent #8,198,319[6]
- Composition and method for treating diabetes and metabolic disorders, Patent #7,943,164[7]
- Composition and method for inhibiting reverse transcript of a retrovirus, Patent #6,319,711[8]
- Levo-monosaccharide in a nucleoside analog for use as an anti-retroviral agent, Patent #6,090,602[9]
- A non-invasive blood glucose measuring device
- The Grapefruit Solution, a nutraceutical grapefruit-based compound which provides clinically documented weight loss without a change in diet or exercise.
- A natural-based food supplement and pharmaceutical that buffers the sugar in foods and drinks to make foods safer for diabetics and healthier for the population at large.
Books
The Grapefruit Solution: Lower Your Cholesterol, Lose Weight and Achieve Optimal Health with Nature’s Wonder Fruit (LINX Corp., 2004), with M. Joseph Ahrens [10]